EGCG is a compound capable of inhibiting the activity of the ERCC1/XPF protein in non-small cell lung cancer cell lines, blocking the intrastrand crosslink repair, and thus enhancing the cytotoxic activities of cisplatin, preventing proliferation and increasing cellular death (58). The gene discussed is ERCC1; the disease is non-small cell lung carcinoma.